Loading…
5 companies · GEL, thousands · columns ordered by revenue
GEL, thousands · money Σ · ratios from summed bases · growth on the pooled series
| Metric | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 9,474 | 15,185 | 19,867 | 22,096 | 25,365 | 25,998 | 27,230 |
| EBITDA | 1,739 | 2,784 | 3,708 | 3,887 | 2,673 | 2,858 | 3,174 |
| Net profit | 1,377 | 2,114 | 3,944 | 3,092 | 1,533 | 1,231 | 1,959 |
| Total assets | 5,225 | 7,257 | 7,749 | 11,735 | 12,770 | 14,406 | 18,270 |
| n (companies reporting) | 3 | 4 | 4 | 5 | 5 | 5 | 5 |
GEL, thousands
| Company | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|---|---|---|---|
| Kava Pharma | — | 0 | 3,932 | 4,577 | 5,414 | 7,431 | 8,427 |
| Zion Development | — | — | — | 0 | 3,463 | 4,794 | 5,362 |
| N-Pharma | 0 | 2,512 | 1,169 | 2,849 | 5,364 | 5,110 | 5,179 |
| Piluet Georgia | 8,737 | 11,105 | 12,875 | 12,271 | 7,781 | 5,161 | 4,985 |
| Eco Resurs Nattek | 737 | 1,567 | 1,891 | 2,398 | 3,342 | 3,503 | 3,276 |
Rows are the raw pool — every peer, including any excluded from the sums above, so the de-duplication stays auditable. Tinted cells are the excluded company-years.
Peer coverage varies by year — FY2018–FY2021 pool fewer than the 5 picked companies (see the n row). A year is never dropped because one peer is missing.
Pooled figures sum every peer in the set. Known parent/subsidiary groups that file separately are de-duplicated; groups not yet curated may still be counted more than once.